Biography:
Dr. Umer Bin Abdul Aziz earned his PharmD from GCUF, Pakistan, in 2010, and gained substantial experience in clinical and hospital pharmacy in Pakistan and the UAE. Moving to Berlin in 2016, he completed MSc in Pharmaceutical Research in 2018, followed by a PhD in Medicinal Chemistry at Freie Universität Berlin, focusing on anti-infective drug development. Since 2023, he is leading a translational research project on anti-virulence therapies as a Project Leader in the lab of Prof. Jörg Rademann at Freie Universität Berlin. Dr. Aziz has published multiple research articles and specializes in pre-clinical studies.
Title : Pathoblockers: A novel anti-virulence approach to combat bacterial infections by targeting cholesterol-dependent cytolysins